Live Chat on The Biotech Forum sees frequent discussion of specific covered call ideas. To see what covered call trades I am currently executing along with a model portfolio of attractive biotech stocks, just initiate your free trial into The Biotech Forum by clicking HERE .Some chinks are finally to develop around the AI narrative. Some investors are also finally asking some hard questions behind this key driver of the market and the economy. Even major central banks have this bubble increasingly poppingBr ...

MicroStockHub/iStock via Getty Images Listen here or on the go via Apple Podcasts and Spotify How to trade and invest in the biotech space with ROTY Biotech Community's Jonathan Faison (0:35). Making money in biotech (5:40). Managing sector risk (9:20). Geron - a stock he never thought he'd own (17:10). Transcript Rena Sherbill: Jonathan Faison from ROTY Biotech Community on Seeking Alpha. That's the investing group you run. Jonathan, welcome back to Investing Experts. Jonathan Faison: Thank you, Ren ...

Live Chat on The Biotech Forum sees frequent discussion of specific covered call trades. To see what covered call trades I am currently executing along with a model portfolio of attractive biotech stocks, just initiate your free trial into The Biotech Forum by clicking HERE .I thought I would do something different for my column today. I will try to peer out into the next year and make three way-too-early predictions for 2026. They follow below.Bret leads the investing group The Biotech Forum , in which he ...

Live Chat on The Biotech Forum sees frequent discussion of specific covered call trades. To see what covered call trades I am currently executing along with a model portfolio of attractive biotech stocks, just initiate your free trial into The Biotech Forum by clicking HERE .I recently came across an interesting article earlier this week diving into some of the greatest market bubbles in history. These range from the South Sea Bubble, the birth of railroads in the United States, the advent of automobiles, r ...

If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?My Buy call on Intellia Therapeutics, Inc. (NASDAQ: NTLA ) stock made in a Seeking Alpha post published last month—August 15th, to be precise—has already paid off. Shares have been soaring in value thisThe group is ...

Group 1 - Pfizer Inc. is a major player in the pharmaceutical industry, with its share price reaching $60 during the pandemic due to the success of its COVID vaccine Comirnaty [1] - The company is part of a broader investment group focused on biotech, pharma, and healthcare, providing insights on market trends and catalysts that influence stock valuations [1] - The investment group offers detailed financial analyses, including product sales forecasts and discounted cash flow analysis for major pharmaceutical companies [1] Group 2 - The article emphasizes the importance of staying updated on stocks within the biotech and healthcare sectors for both novice and experienced investors [1] - The author, Edmund Ingham, has extensive experience in the biotech field, having covered over 1,000 companies and providing detailed reports [1]

Group 1 - The company has a strong academic foundation with an MBA in Finance and an MD, enhancing its expertise in the financial sector [1] - The firm specializes in income investing and biotech/pharma investing, with nearly a decade of experience in these areas [2] - The organization focuses on identifying both short-term catalyst-driven opportunities and long-term investment strategies in the biotech sector [3] Group 2 - Subscribers receive regular portfolio trade alerts and have access to an interactive chat feature, promoting engagement and support [4] - The company has published a best-selling book on biotech investing and offers an online course, showcasing its commitment to educating investors [4] - The firm provides custom biotech analysis upon request, ensuring tailored insights for its audience [4]

Group 1 - The article highlights DexCom, Inc. (NASDAQ: DXCM) as a focus for investment, particularly noting a temporary stock boost of 10% in late June due to an announcement from the Department of Health and Human Services [1] - The Biotech Forum, led by Bret, offers a model portfolio featuring 12-20 high upside biotech stocks, along with live chat discussions and weekly research updates [1] - The forum emphasizes covered call opportunities in the biotech sector, indicating a trend among seasoned investors [1]

Group 1 - Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) has seen increased momentum following the release of long-term data from its studies on Casgevy, a therapy for Sickle Cell Disease and transfusion-dependent Beta-Thalassemia [1] - The Haggerston BioHealth investing group provides insights for both novice and experienced biotech investors, including catalysts, buy and sell ratings, product sales forecasts, and integrated financial statements [1] - The group is led by a biotech consultant with over 5 years of experience in covering biotech, healthcare, and pharma, having compiled detailed reports on over 1,000 companies [1]

Group 1 - The company has a strong academic foundation with an MBA in Finance and an MD, enhancing its expertise in the financial sector [1] - The company operates as a registered investment advisor and professional money manager, focusing on income investing and biotech/pharma investing [2] - The company emphasizes community building for sharing and thriving breakthrough investment ideas in the biotech/pharma industry [2] Group 2 - The company provides in-depth analysis of income investing and long-term takeover potential biotech/pharma stocks, identifying both short-term and long-term investment opportunities [3] - The company offers tailored biotech analysis and regular portfolio trade alerts, facilitating investor engagement and confidence in navigating biotech investments [4] - The company has authored a top-selling book on biotech investing and provides educational resources through an online course [4]